2. Academic Validation
  3. Necroptosis induced by ruthenium (II) complexes as mitochondrial disruptors

Necroptosis induced by ruthenium (II) complexes as mitochondrial disruptors

  • Cell Death Discov. 2024 May 28;10(1):261. doi: 10.1038/s41420-024-02033-z.
Joana Gonçalves 1,  Joana D Amaral 1,  Rita Capela 1,  Maria de Jesus Perry 1,  Cláudia Braga 1,  Maria Manuela Gaspar 1 2,  Fátima M Piedade 3 4,  Lubertus Bijlsma 5,  Antoni Roig 5,  Sandra N Pinto 6,  Rui Moreira 1,  Pedro Florindo 1,  Cecília M P Rodrigues 7
Affiliations

Affiliations

  • 1 Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
  • 2 Instituto de Biofísica e Engenharia Biomédica, Faculty of Sciences, Universidade de Lisboa, Lisbon, Portugal.
  • 3 Departamento de Química e Bioquímica, Faculty of Sciences, Universidade de Lisboa, Lisbon, Portugal.
  • 4 Centro de Química Estrutural, Institute of Molecular Sciences, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
  • 5 Environmental and Public Health Analytical Chemistry, Research Institute for Pesticides and Water, University Jaume I, Castelló, Spain.
  • 6 iBB-Institute for Bioengineering and Biosciences, Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
  • 7 Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal. cmprodrigues@ff.ulisboa.pt.
PMID: 38806468 DOI: 10.1038/s41420-024-02033-z
Abstract

Inducing Necroptosis in Cancer cells has emerged as an effective strategy to overcome drug resistance. However, while organic small molecules have been extensively studied for this purpose, metal-based compounds have received relatively little attention as triggers of Necroptosis. The development of ruthenium (II) hybrid compounds, particularly those containing triazene (Ru-TRZ), highlights a novel avenue for modulating necroptotic cell death. Here we show that incorporating a methyltriazene moiety, a known alkylating warhead, confers superior mitochondrial-targeting properties and enhances cell death compared to amide-containing counterparts. Ru-hybrid TRZ2 exhibits also antitumor efficacy against in vivo drug-resistant Cancer cells. Mechanistically, we demonstrate that Ru-TRZ hybrids induce Apoptosis. In addition, by activating downstream RIPK3-driven cell death, TRZ2 proficiently restrains normal mitochondrial function and activity, leading to Cancer cell Necroptosis. Finally, TRZ2 synergizes anti-proliferative activity and cell death effects induced by conventional drugs. In conclusion, Ru-TRZ2 stands as a promising ruthenium-based chemotherapeutic agent inducing Necroptosis in drug resistant Cancer cells.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z